Table 3: Summary of available epidemiologic data by outcome and country.

Total NHLDLBCL and FLAdult ALLPediatric ALLMMCLL

North and South AmericaIPSIPSIPSIPSIPSIPS

United States
Canada * *
Brazil*†*†*†

European Union-5IPSIPSIPSIPSIPSIPS

United Kingdom
England
Ireland
Republic of Ireland
Northern Ireland
Scotland
Wales *
France *
Germany * *
Italy * *
Spain *† * *†

AsiaIPSIPSIPSIPSIPSIPS

China * *†*† * *†
Japan
South Korea * * *† * * * * *†
India*†*†*†*†

AustraliaIPSIPSIPSIPSIPSIPS

Australia *

ALL: acute lymphoblastic leukemia; CLL: chronic lymphocytic leukemia; DLBCL: diffuse large B-cell lymphoma; FL: follicular lymphoma; I: incidence; MM: multiple myeloma; NHL: non-Hodgkin’s lymphoma; P: prevalence; S: survival.
*Data on lymphoid leukemia were used as a proxy for ALL and CLL.
Regional estimates were used a proxy for national estimates.